Gilead Sciences, Inc. GILD announced that the FDA has granted accelerated approval to Hepcludex (bulevirtide-gmod) for adults with chronic hepatitis delta virus (HDV) infection. The approval makes ...
The biotechnology and drug manufacturing market continues to give investors a hit-and-miss. Bears are betting heavily against Hims and Hers (HIMS), holding a short interest of 28.31%. On May 21, Hims ...
A new experiment is seeking to validate whether living cancer samples can be prepared, operated, monitored, and recovered ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results